Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market

Core Insights - Wellgistics Health has entered into a software as a service (SAAS) agreement with DataVault AI to develop a blockchain-enabled tracking and dispensing platform for the prescription drug market, named PharmacyChain™ [2][3] - The partnership aims to optimize Wellgistics' technology and infrastructure, with beta testing expected in the first half of 2026 [2][4] - The prescription drug market is valued at $639 billion, indicating significant potential for revenue generation through this collaboration [2][7] Company Overview - Wellgistics Health, Inc. is a leader in pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, connecting over 6,500 pharmacies and 200 manufacturers [8] - The company aims to restore access, transparency, and trust in U.S. healthcare through its integrated platform [8] Technology and Innovation - The PharmacyChain™ platform will utilize smart contracts to enhance the efficiency of prescription fulfillment, allowing pharmacies to securely receive and transfer data [4][6] - DataVault AI's technology will enable the creation of Digital Twins for pharmaceutical logistics and patient data, facilitating personalized healthcare recommendations based on individual health profiles [7] Market Impact - The collaboration is expected to attract significant interest from manufacturers, pharmacists, and insurers, enhancing the overall efficiency of the prescription fulfillment process [4] - The integration of diagnostic and biometric data is planned to further empower healthcare professionals and improve patient outcomes [6]